Effect of acidic ternary compounds on the formation of miconazole/cyclodextrin inclusion complexes by means of supercritical carbon dioxide

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 7, Issue 3, 2004, Pages 378-388

  Barillaro, Valéry ^a   Bertholet, Pascal ^a   de Hassonville, Sandrine Henry ^a   Ziemons, Eric ^a   Evrard, Brigitte ^a   Delattre, Luc ^a   Piel, Géraldine ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; CITRIC ACID; CYCLODEXTRIN; FUMARIC ACID; MALEIC ACID; MALIC ACID; MICONAZOLE; MICONAZOLE NITRATE; TARTARIC ACID;

ARTICLE; COMPLEX FORMATION; CONFORMATION; CONTROLLED STUDY; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG MIXTURE; DRUG STABILITY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; SOLUBILITY; TEMPERATURE; THERMAL ANALYSIS; TIME;

CARBON DIOXIDE; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; HYDROGEN-ION CONCENTRATION; MICONAZOLE;

EID: 27444434650     PISSN: 14821826     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Uekama, K.; Hirayama, F.; Irie, T. Cyclodextrin drug carrier systems. Chem. Rev. 98: 2045-2076, 1998
2. Loftsson, T.; Fririksdottir, H. The effect of water-soluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin. Int. J. Pharm. 163: 115-121,1998
3. Mura, P.; Faucci, M. T.; Manderioli, A.; Bramanti, G. Multicomponent system of econazole with hydroxy-acids and cyclodextrins. J. Incl. Phenom. Macro. 39: 131-138,2001
4. iel, G.; Pirotte, B.; Delneuville, I.; Neven, P.; Llabres, G.; Delarge, J.; Delattre, L. Study of the influence of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide; isolation and characterization of nimesulide-L-lysine-cyclodextrin complexes. J. Pharm. Sci. 86: 475-480,1997
5. Van Hees, T.; Piel, G.; Evrard, B.; Otte, X; Thunus, L.; Delattre, L. Application of supercritical fluid carbon dioxide for the preparation of a piroxicam-β-cyclodextrin inclusion compound. Pharm. Res. 16: 1864-1870,1999
6. Charoenchaitrakool, M.; Dehghani, F.; Foster, N. R. Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-β-cyclodextrin. Int. J. Pharm. 239: 103-112,2002
7. Piel, G.; Dive, G.; Evrard, B.; Van Hees, T.; Henry de Hassonville, S.; Delattre, L. Molecular modeling study of β- and γ-cyclodextrin complexes with miconazole. Eur. J. Pharm. Sci. 13: 271-279,2001
8. Pedersen, M. Isolation and antimycotic effect of a genuine miconazole beta-cyclodextrin complex. Eur. J. Pharm. Biopharm. 40: 19-23,1994
9. Jacobsen, J.; Bjerregaard, S.; Pedersen, M. Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity - drug supersaturation, toxicity on TR146 cells and release from a delivery system. Eur. J. Pharm. Biopharm. 48: 217-224,1999
10. Piel, G.; Evrard, B.; Fillet, M.; Llabres, G.; Delattre, L. Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. Int. J. Pharm. 169: 15-22,1998
11. Caporal-Gauthier, J.; Nivet, J. M.; Algrande, P. Guide de validation analytique: rapport d'une commission SFSTP. I. Méthodologie. STP Pharma Pratiques, 2: 205-226,1992
12. Van Hees, T.; Piel, G.; Henry de Hassonville, S.; Evrard, B.; Delattre, L. Determination of the free/included piroxicam ratio in cyclodextrin complexes: comparison between UV spectroscopy and differential scanning calorimetry. Eur. J. Pharm. Sci. 15: 347-353, 2002
13. Pedersen, M.; Pedersen, S.; Sorensen, A. M. Polymorphism of miconazole during preparation of solid systems of the drug and β-cyclodextrins. Pharmaceutica Acta Helvetiae, 68: 43-47,1993
14. Drake, B.; Smith, R. Measurement of static dielectric constants of supercritical fluid solvents and cosolvents. J. Supercrit. Fluids, 3: 162,1990
15. Bueno, J. L.; Suarez, J. J.; Dizy, J.; Medina, I. Infinite dilution diffusion coefficients: benzene derivatives as solutes in supercritical Carbon Dioxide. J. Chem. Eng. Data, 38: 344-349,1993
16. Loftsson, T.; Brewster, M. E. Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization. J. Pharm. Sci. 85: 1017-1025,1996
17. Redenti, E.; Ventura, P.; Fronza, G.; Selva, A.; Rivara, S.; Plazzi, P. V.; Mor, M. Experimental and theoretical analysis of the interaction of (+/-)-cis-ketoconazole with β-cyclodextrin in the presence of (+)-L-tartaric acid. J. Pharm. Sci. 88: 599-607,1999
18. Piel, G.; Llabres, G.; Evrard, B.; Van Hees, T.; Henry de Hassonville, S.; Delattre, L. A nuclear magnetic resonance study of the miconazole-β-cyclodextrin inclusion complex in an acidic medium: Determination of the structure and stability constants. S. T. P. Pharma Sci. 11: 235-238,2001
19. 7M-βCD to HP-β-CD. Pharm. Res. 18: 667-673,2001
20. Szejtli, J. Cyclodextrin Technology. Kluwer Academic Publishers: Dordrecht, 1988.
21. Muños de la Peña, A.; Ndou, T. T.; Zung, J. B.; Greene, K. L.; Live, D. H.; Warner, I. M. Alcohol size as a factor in the ternary complexes formed with pyrene and β-cyclodextrin. J. Am. Chem. Soc. 113: 1572-1577,1991
22. Mura, P.; Maestrelli, F.; Cirri, M. Ternary systems of naproxen with hydroxypropyl-β-cyclodextrin and aminoacids. Int. J. Pharm. 260: 293-302,2003